Non‑coding RNA‑mediated Epigenetic Modification of Ferroptosis in Non‑small Cell Lung Cancer (Review)

Overview

Journal Int J Oncol

Specialty Oncology

Date 2024 Dec 13

PMID 39670309

Authors

Yumin Wang

Joshua S Fleishman

Yulin Li

Yuwei Cao

Haidong Wei

Zhe Zhang

Jichao Chen

Mingchao Ding

Affiliations

Soon will be listed here.

Abstract

Ferroptosis is a novel form of regulated cell death that plays a key role in inhibiting tumor malignancy. The ferroptosis signalling cascade provides new opportunities for lung cancer therapy. Non‑coding RNA (ncRNA)‑mediated epigenetic modification can influence the vulnerability of cancer cells to ferroptosis in non‑small‑cell lung cancer (NSCLC). The present review describes the core molecular mechanisms underlying ferroptosis and the role of epigenetic mechanisms in regulating ferroptosis in NSCLC, as well as developments in understanding the ncRNA‑induced mechanisms that affect ferroptosis in NSCLC. The present review aimed to enhance understanding of the epigenetic mechanisms mediated by ncRNAs that modulate ferroptosis in NSCLC, highlighting a novel therapeutic strategy for NSCLC via the ncRNA‑ferroptosis axis.

References

Adhikari S, Bhattacharya A, Adhikary S, Singh V, Gadad S, Roy S . The paradigm of drug resistance in cancer: an epigenetic perspective. Biosci Rep. 2022; 42(4). PMC: 9069444. DOI: 10.1042/BSR20211812. View

Stockwell B, Friedmann Angeli J, Bayir H, Bush A, Conrad M, Dixon S . Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017; 171(2):273-285. PMC: 5685180. DOI: 10.1016/j.cell.2017.09.021. View

Sun L, Cao H, Wang Y, Wang H . Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma. Biol Direct. 2024; 19(1):80. PMC: 11391853. DOI: 10.1186/s13062-024-00530-w. View

Luo Y, Huang Q, He B, Liu Y, Huang S, Xiao J . Regulation of ferroptosis by non‑coding RNAs in the development and treatment of cancer (Review). Oncol Rep. 2020; 45(1):29-48. PMC: 7709825. DOI: 10.3892/or.2020.7836. View

Li Y, Ran Q, Duan Q, Jin J, Wang Y, Yu L . 7-Dehydrocholesterol dictates ferroptosis sensitivity. Nature. 2024; 626(7998):411-418. PMC: 11298758. DOI: 10.1038/s41586-023-06983-9. View

Stockwell B, Jiang X . The Chemistry and Biology of Ferroptosis. Cell Chem Biol. 2020; 27(4):365-375. PMC: 7204503. DOI: 10.1016/j.chembiol.2020.03.013. View

Koppula P, Zhang Y, Zhuang L, Gan B . Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018; 38(1):12. PMC: 5993148. DOI: 10.1186/s40880-018-0288-x. View

Ensoy M, Bumin Z, Jama H, Cansaran-Duman D . The Regulation Role of Ferroptosis Mechanism of Anti-Cancer Drugs and Noncoding RNAs. Curr Med Chem. 2022; 30(14):1638-1656. DOI: 10.2174/0929867329666220629154418. View

Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K . Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis. Cell. 2018; 172(3):409-422.e21. DOI: 10.1016/j.cell.2017.11.048. View

10.

Xu P, Wang L, Xie X, Hu F, Yang Q, Hu R . Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression. Aging (Albany NY). 2020; 12(23):23836-23848. PMC: 7762492. DOI: 10.18632/aging.104037. View

11.

Yan B, Ai Y, Sun Q, Ma Y, Cao Y, Wang J . Membrane Damage during Ferroptosis Is Caused by Oxidation of Phospholipids Catalyzed by the Oxidoreductases POR and CYB5R1. Mol Cell. 2020; 81(2):355-369.e10. DOI: 10.1016/j.molcel.2020.11.024. View

12.

Pan C, Wei K, Ma Z, He Y, Huang J, Guo Z . CircP4HB regulates ferroptosis via SLC7A11-mediated glutathione synthesis in lung adenocarcinoma. Transl Lung Cancer Res. 2022; 11(3):366-380. PMC: 8988082. DOI: 10.21037/tlcr-22-138. View

13.

Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R . Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2015; 63(1):173-84. PMC: 4688087. DOI: 10.1002/hep.28251. View

14.

Zhao R, Fu J, Zhu L, Chen Y, Liu B . Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy. J Hematol Oncol. 2022; 15(1):14. PMC: 8817562. DOI: 10.1186/s13045-022-01230-6. View

15.

Kang M, Fujino T, Sasano H, Minekura H, Yabuki N, Nagura H . A novel arachidonate-preferring acyl-CoA synthetase is present in steroidogenic cells of the rat adrenal, ovary, and testis. Proc Natl Acad Sci U S A. 1997; 94(7):2880-4. PMC: 20291. DOI: 10.1073/pnas.94.7.2880. View

16.

Jacquemyn J, Ralhan I, Ioannou M . Driving factors of neuronal ferroptosis. Trends Cell Biol. 2024; 34(7):535-546. DOI: 10.1016/j.tcb.2024.01.010. View

17.

Zhang N, Huang J, Xu M, Wang Y . LncRNA T-UCR Uc.339/miR-339/SLC7A11 Axis Regulates the Metastasis of Ferroptosis-Induced Lung Adenocarcinoma. J Cancer. 2022; 13(6):1945-1957. PMC: 8990432. DOI: 10.7150/jca.65017. View

18.

Yunchu Y, Miyanaga A, Seike M . Integrative Analysis of Ferroptosis-Related Genes in Small Cell Lung Cancer for the Identification of Biomarkers and Therapeutic Targets. Front Biosci (Landmark Ed). 2023; 28(6):125. DOI: 10.31083/j.fbl2806125. View

19.

Nakamura T, Hipp C, Mourao A, Borggrafe J, Aldrovandi M, Henkelmann B . Phase separation of FSP1 promotes ferroptosis. Nature. 2023; 619(7969):371-377. PMC: 10338336. DOI: 10.1038/s41586-023-06255-6. View

20.

Soerjomataram I, Bray F . Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nat Rev Clin Oncol. 2021; 18(10):663-672. DOI: 10.1038/s41571-021-00514-z. View